Form 4: Merit Medical Systems Executive Voigt Michel James Reports Changes in Beneficial Ownership

Voigt Michel James, Chief Human Resources Officer at Merit Medical Systems, reports transactions involving common stock and stock options, including acquisitions, disposals, and vesting of restricted stock units and performance stock units.

Summary

• On March 4, 2024, Voigt Michel James acquired 5,228 shares of common stock through a grant of restricted stock units (RSUs).
• These RSUs vest in four equal annual installments.
• Also on March 4, 2024, 7,110 shares were acquired upon meeting certain conditions for performance stock units granted on March 19, 2021.
• 2,630 shares were disposed of on March 4, 2024, to satisfy tax withholding obligations at a price of $76.51 per share.
• On March 6, 2024, 315 shares were transferred.
• As of March 4, 2024, Voigt Michel James directly owns 9,908 shares and indirectly owns 15 shares through a 401(k) plan.
• He also holds non-qualified stock options to purchase 9,681 shares at $56.25 (exercisable from March 19, 2022), 8,094 shares at $65.03 (exercisable from February 28, 2023), and 13,576 shares at $70.58 (exercisable from February 28, 2024).

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisitions of shares through RSUs and performance stock units are positive signals, while the disposal of shares for tax obligations is a routine event. Overall, the filing suggests continued alignment of the executive's interests with the company's performance.

Positives

• The acquisition of shares through RSUs and performance stock units indicates confidence in the company's future performance.

Negatives

• The disposal of 2,630 shares to cover tax obligations, while routine, represents a slight reduction in direct ownership.

Risks

• Future vesting of RSUs and performance stock units is contingent upon continued service, creating a potential risk if the reporting person leaves the company.

Future Outlook

The vesting schedule of the RSUs and the exercisability of the stock options suggest a continued alignment of the executive's interests with the company's long-term performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Comparison to Industry Standards

• Stock option grants and RSU awards are common compensation practices in the medical device industry, used to incentivize and retain key executives.
• Companies like Medtronic, Stryker, and Boston Scientific also utilize similar equity-based compensation plans.
• The vesting schedules and exercise prices are generally in line with industry norms for executive compensation.

Stakeholder Impact

• The transactions reported in the Form 4 filing provide transparency to shareholders regarding the executive's ownership stake in the company.
• The equity-based compensation structure aligns the executive's interests with those of the shareholders, incentivizing long-term value creation.

Key Dates